Jeil Pharma Holdings Inc (002620.KS) KSC

8,220.00

-90(-1.08%)

Updated at October 20 09:15AM

Currency In KRW

Jeil Pharma Holdings Inc

Address

343, Sapyeong-daero

Seoul, 06543

Korea, Republic of

Phone

82 2 549 7451

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

35

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Mr. Seung-Soo HanChairman of The Board and Chief Executive Officer01947

Description

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.